Lyrica 75 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

lyrica 75 mg

farmagon - pregabalin - kapsel, hard - 75 mg

Tecfidera 240 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

tecfidera 240 mg

2care4 aps - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 240 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

tecfidera 240 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 120 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

tecfidera 120 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 120 mg

Cymbalta 30 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

cymbalta 30 mg

2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 30 mg

Cymbalta 60 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

cymbalta 60 mg

2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 60 mg

Sutent यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Xenical 120 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

xenical 120 mg

orifarm as - orlistat - kapsel, hard - 120 mg

Retsevmo यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Xenical 120 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

xenical 120 mg

farmagon - orlistat - kapsel, hard - 120 mg